share_log

Takeda Pharmaceutical | 6-K: Announcement of a company split (simplified absorption-type company split/short-form company split) with a wholly-owned subsidiary

SEC ·  Jan 16 13:00
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.